Literature DB >> 21295189

Aortic valve sclerosis and clinical outcomes: moving toward a definition.

S Michael Gharacholou1, Barry L Karon, Clarence Shub, Patricia A Pellikka.   

Abstract

The presence of aortic valve sclerosis has been suggested as a marker of increased cardiovascular risk, including increased mortality. However, it remains unclear whether aortic valve sclerosis is independently associated with risk or merely a marker of coexistent cardiovascular risk factors. Aortic valve sclerosis is usually diagnosed on transthoracic echocardiography, the most widely used imaging modality in observational and natural history studies of aortic valve disease. Defining aortic valve sclerosis has remained challenging due to the variable and qualitative nature of its description by ultrasound techniques. Importantly, artifacts common to ultrasound imaging and awareness of demographic and clinical history information may bias the diagnosis of aortic valve sclerosis. Because clinicians may alter treatment recommendations or follow-up based on echocardiographic reporting of aortic valve sclerosis, highlighting pitfalls of the subjective nature by which aortic valve sclerosis is identified and establishing diagnostic criteria are necessary. This review describes the diagnostic criteria for aortic valve sclerosis used in outcome studies, summarizes the epidemiological findings reporting the relationship between aortic valve sclerosis and clinical outcome, and proposes a definition of aortic valve sclerosis based on the literature.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21295189     DOI: 10.1016/j.amjmed.2010.10.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  19 in total

1.  Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with type 2 diabetes mellitus without myocardial ischemia.

Authors:  Giovanni Cioffi; Giorgio Faganello; Stefania De Feo; Nicola Berlinghieri; Luigi Tarantini; Andrea Di Lenarda; Bruno Pinamonti; Riccardo Candido; Pompilio Faggiano
Journal:  Exp Clin Cardiol       Date:  2013

Review 2.  Heart Valve Biomechanics and Underlying Mechanobiology.

Authors:  Salma Ayoub; Giovanni Ferrari; Robert C Gorman; Joseph H Gorman; Frederick J Schoen; Michael S Sacks
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

3.  Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease.

Authors:  Rachana Sainger; Juan B Grau; Emanuela Branchetti; Paolo Poggio; Eric Lai; Erblina Koka; William J Vernick; Robert C Gorman; Joseph E Bavaria; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2013-03

4.  Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease.

Authors:  Juan B Grau; Paolo Poggio; Rachana Sainger; William J Vernick; William F Seefried; Emanuela Branchetti; Benjamin C Field; Joseph E Bavaria; Michael A Acker; Giovanni Ferrari
Journal:  Ann Thorac Surg       Date:  2011-11-16       Impact factor: 4.330

5.  Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis.

Authors:  Emanuela Branchetti; Rachana Sainger; Paolo Poggio; Juan B Grau; Jeffrey Patterson-Fortin; Joseph E Bavaria; Michael Chorny; Eric Lai; Robert C Gorman; Robert J Levy; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

6.  Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

Authors:  Paolo Poggio; Rachana Sainger; Emanuela Branchetti; Juan B Grau; Eric K Lai; Robert C Gorman; Michael S Sacks; Alessandro Parolari; Joseph E Bavaria; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2013-03-12       Impact factor: 10.787

7.  Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients.

Authors:  Andrea Rossi; Pompilio Faggiano; Alexandra E Amado; Mariantonietta Cicoira; Stefano Bonapace; Lorenzo Franceschini; Frank L Dini; Stefano Ghio; Eustachio Agricola; Pier Luigi Temporelli; Corrado Vassanelli
Journal:  Heart Vessels       Date:  2013-11-07       Impact factor: 2.037

Review 8.  Cardiac valve cells and their microenvironment--insights from in vitro studies.

Authors:  Huan Wang; Leslie A Leinwand; Kristi S Anseth
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 9.  Dissecting Calcific Aortic Valve Disease-The Role, Etiology, and Drivers of Valvular Fibrosis.

Authors:  Petra Büttner; Lukas Feistner; Philipp Lurz; Holger Thiele; Joshua D Hutcheson; Florian Schlotter
Journal:  Front Cardiovasc Med       Date:  2021-05-10

10.  Discordant severity criteria in patients with moderate aortic stenosis: prognostic implications.

Authors:  Stephan M Pio; Mohammed R Amanullah; Steele C Butcher; Kenny Y Sin; Nina Ajmone Marsan; Philippe Pibarot; Nicolas M Van Mieghem; Zee Pin Ding; Philippe Généreux; Martin B Leon; See Hooi Ewe; Victoria Delgado; Jeroen J Bax
Journal:  Open Heart       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.